Uğur Şahin, Özlem Türeci, Tedros Adhanom Ghebreyesus and Holm Keller in Marburg (Andreas Arnold/picture-alliance/dpa/AP Images)

BioN­Tech un­veils a 'cheap' ship­ping-con­tain­er kit for man­u­fac­tur­ing vac­cines glob­al­ly

What do you get when you com­bine 12 ship­ping con­tain­ers and some of the most in­no­v­a­tive sci­ence sur­round­ing vac­cines there is?

A fu­tur­is­tic way to make in-de­mand vac­cines.

BioN­Tech has made it known for months now that it wants to es­tab­lish do­mes­tic man­u­fac­tur­ing ops for vac­cines in Africa, where ac­cess is a big is­sue and vac­ci­na­tion rates for Covid trail well be­hind af­flu­ent coun­tries. And on Wednes­day the com­pa­ny re­vealed its first “mod­u­lar” mR­NA man­u­fac­tur­ing fa­cil­i­ties in Sene­gal, Rwan­da and “po­ten­tial­ly South Africa.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.